The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Kountouras C., Vardaka E., et al. (2016).  Potential molecular aspects of Helicobacter pylori-related hyperplastic polyp development and progression.. Eur J Gastroenterol Hepatol. 28(7), 851-2.
Kountouras, J., Gavalas E., Polyzos S. A., Deretzi G., Kouklakis G., Grigoriadis S., et al. (2014).  Association between Helicobacter pylori burden and Alzheimer's disease.. Eur J Neurol. 21(12), e100.
Kountouras, J., Zavos C., Deretzi G., Polyzos S. A., Gavalas E., Tsiaousi E., et al. (2011).  Neuroprotection in glaucoma: is there a future role of Helicobacter pylori eradication?. Exp Eye Res. 92(5), 436-8.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Tzitiridou-Chatzopoulou M., Chatzopoulos D., et al. (2022).  Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease.. Metabolism. 135, 155276.
Kountouras, J., Zavos C., Deretzi G., Gavalas E., Polyzos S., Vardaka E., et al. (2011).  Helicobacter pylori may play an important role in both axonal type Guillain-Barré syndrome and acute inflammatory demyelinating polyradiculoneuropathy.. Clin Neurol Neurosurg. 113(6), 520.
Kountouras, J., Tsiaousi E., Trigonis S., Polyzos S. A., Katsinelos P., Zavos C., et al. (2016).  Comment on "The correlation of Helicobacter pylori with the development of cholelithiasis and cholecystitis: the results of a prospective clinical study in Saudi Arabia".. Eur Rev Med Pharmacol Sci. 20(1), 3-4.
Kountouras, J., Doulberis M., Polyzos S. A., Tzitiridou M., Chatzopoulos D., Gialamprinou D., et al. (2022).  A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery.. Gastrointest Endosc. 96(6), 1088-1089.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Vardaka E., Boziki M., Kyriakopoulos A., et al. (2021).  Impact of -related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders.. J Neurogastroenterol Motil. 27(4), 653-654.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Touloumtzi M., Elisabeth V., et al. (2019).  Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a double-edged sword reflection.. Cell Mol Life Sci. 76(13), 2487-2488.
Kountouras, J., Kapetanakis N., Zavos C., Polyzos S. A., Vardaka E., Katsinelos P., et al. (2014).  Helicobacter pylori and colorectal cancer risk--letter.. Cancer Epidemiol Biomarkers Prev. 23(2), 365.
Kountouras, J., Zavos C., Polyzos S. A., Romiopoulos I., Stergiopoulos C., Tsiaousi E., et al. (2013).  Is Helicobacter pylori the usual suspect behind gastroesophageal reflux disease and dacryostenosis?. Med Hypotheses. 81(1), 147.
Kountouras, J., Kazakos E., Gatopoulou A., Polyzos S. A., Touloumtzi M., Kyrailidi F., et al. (2023).  Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels.. Aliment Pharmacol Ther. 58(11-12), 1252-1253.
Kountouras, J., Deretzi G., Zavos C., Gavalas E., Polyzos S. A., Klonizakis P., et al. (2012).  Helicobacter pylori's potential association with epilepsy.. Seizure. 21(2), 151.
Kountouras, J., Polyzos S. A., Gavalas E., Boziki M., Katsinelos P., Zeglinas C., et al. (2016).  A potential impact of Helicobacter pylori infection on minimal hepatic encephalopathy pathobiology.. J Gastrointestin Liver Dis. 25(3), 405-6.
Kountouras, J., Deretzi G., Zavos C., & Katsinelos P. (2014).  A possible impact of common worldwide environmental agents on the prognosis of critically ill cirrhotic patients.. Liver Int. 34(7), 1127-8.
Kountouras, J., Patsiaoura K., Zavos C., Chatzopoulos D., Katsinelos P., Tantsi N., et al. (2014).  Letter: apoptosis and hepatic fibrosis in chronic hepatitis B.. Aliment Pharmacol Ther. 39(9), 996.
Kountouras, J., Boziki M., Gavalas E., Zavos C., Grigoriadis N., Deretzi G., et al. (2009).  Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease.. J Neurol. 256(5), 758-67.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Vardaka E., Touloumtzi M., et al. (2022).  Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension.. Arq Bras Cardiol. 119(3), 502-504.
Kountouras, J., Zavos C., Polyzos S. A., & Deretzi G. (2016).  Potential impact of Helicobacter pylori-related human β-defensin-1 on hepatic encephalopathy and neurodegeneration.. Ann Gastroenterol. 29(1), 99.
Kountouras, J., Doulberis M., Polyzos S. A., & Katsinelos P. (2019).  Metabolic syndrome components including high abdominal obesity and sarcopenia in patients with inflammatory bowel disease.. Ann Gastroenterol. 32(2), 214.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Tzilves D., Touloumtzi M., et al. (2023).  Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities.. Aliment Pharmacol Ther. 57(10), 1186-1187.
Kountouras, J., Gavalas E., Papaefthymiou A., Tsechelidis I., Polyzos S. A., Bor S., et al. (2020).  Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial.. Medicina (Kaunas). 56(7), 
Kountouras, J., Polyzos S. A., Zavos C., Deretzi G., Kountouras C., Vardaka E., et al. (2014).  Helicobacter pylori might contribute to nonalcoholic fatty liver disease-related cardiovascular events by releasing prothrombotic and proinflammatory factors.. Hepatology. 60(4), 1450-1.
Kountouras, J., Zavos C., Gavalas E., Deretzi G., Tsona A., Katsinelos P., et al. (2012).  A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein.. Cancer Immunol Immunother. 61(3), 445-6; discussion 447-51.
Kountouras, J., Kazakos E., Polyzos S. A., Chatzopoulos D., Tzitiridou-Chatzopoulou M., Doulberis M., et al. (2022).  GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection.. Helicobacter. 27(3), e12884.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.